ID
12602
Beskrivning
Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children; ODM derived from: https://clinicaltrials.gov/show/NCT01301313
Länk
https://clinicaltrials.gov/show/NCT01301313
Nyckelord
Versioner (1)
- 2015-12-04 2015-12-04 -
Uppladdad den
4 december 2015
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Acute Heart Failure NCT01301313
Eligibility Acute Heart Failure NCT01301313
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beskrivning
Informed consent denied
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0021430
Beskrivning
cardiomyopathy
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0878544
Beskrivning
aortic stenosis
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0003507
Beskrivning
allergy
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0020517
Beskrivning
it is not possible to prescribe the study medication because it is contraindicated according to the summary of the product characteristic or according to the criteria of the physician responsible for patient
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1301624
- UMLS CUI [2]
- C0009488
Beskrivning
Pregnancy
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0549206
Similar models
Eligibility Acute Heart Failure NCT01301313
- StudyEvent: Eligibility
C0264714 (UMLS CUI [2])
C0009488 (UMLS CUI [2])